GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] we are measuring 503B at the wrong time and calling it noise — 70 comments in the full submission. View in context.
3k
c/compounding·submitted 12 months ago by u/lukas_delgado

[Discussion] we are measuring 503B at the wrong time and calling it noise

Discussionbranch of 8 comments

Posting this as a discussion rather than a claim: we are measuring 503B at the wrong time and calling it noise. Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label. A beyond-use date derived from published…

Read the full submission and all 70 comments →

This branch

8 comments, started 12 months ago
u/camila_sandvik127 points·12 months ago

503A is patient-specific, 503B is outsourcing facility, they are not the same thing

replysharereportpermalink
u/fatima_kowalski97 points·11 months ago

Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.

replysharereportpermalink
u/sofia_nascimento66 points·11 months ago

That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.

replysharereportpermalink
u/bilal_osei23 points·11 months ago

Right, and the concentration genuinely can differ from the branded product, which breaks people’s arithmetic.

replysharereportpermalink
u/tobias_vukovic77 points·11 months ago

if a clinic will not name the facility, that is your answer

replysharereportpermalink
u/jonas_eriksen66 points·11 months ago

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

replysharereportpermalink
u/rafael_ostergaard27 points·11 months ago

ask what the beyond-use date is based on

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.